Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2025
Zimmer Biomet (NYSE:ZBH), a global medical technology leader, has announced its quarterly dividend for Q3 2025. The company's Board of Directors approved a cash dividend of $0.24 per share. The dividend will be paid on or around October 31, 2025 to stockholders of record as of the close of business on September 30, 2025.
Zimmer Biomet (NYSE:ZBH), leader globale nella tecnologia medicale, ha annunciato il dividendo trimestrale per il terzo trimestre 2025. Il Consiglio di Amministrazione della società ha approvato un dividendo in contanti di 0,24 USD per azione. Il dividendo sarà pagato intorno al 31 ottobre 2025 agli azionisti registrati alla chiusura delle attività del 30 settembre 2025.
Zimmer Biomet (NYSE:ZBH), lÃder mundial en tecnologÃa médica, ha anunciado su dividendo trimestral para el tercer trimestre de 2025. El Consejo de Administración de la compañÃa aprobó un dividendo en efectivo de 0,24 USD por acción. El dividendo se pagará en o alrededor del 31 de octubre de 2025 a los accionistas registrados al cierre de operaciones del 30 de septiembre de 2025.
Zimmer Biomet (NYSE:ZBH), ì � 세계 ì˜ë£Œê¸°ìˆ ì„ ë„ ê¸°ì—…ì� 2025ë…� 3분기 분기 배당ì� 발표했습니다. 회사 ì´ì‚¬íšŒëŠ” 주당 미화 0.24달러ì� 현금 배당ì� 승ì¸í–ˆìŠµë‹ˆë‹¤. ì� ë°°ë‹¹ì€ 2025ë…� 10ì›� 31ì� ê²�ì—�, 2025ë…� 9ì›� 30ì� ì˜ì—…종료 시ì 기준 주주ì—게 지급ë ì˜ˆì •ìž…ë‹ˆë‹�.
Zimmer Biomet (NYSE:ZBH), un leader mondial des technologies médicales, a annoncé son dividende trimestriel pour le 3e trimestre 2025. Le conseil d'administration de la société a approuvé un dividende en espèces de 0,24 USD par action. Le dividende sera versé aux alentours du 31 octobre 2025 aux actionnaires inscrits à la clôture des activités du 30 septembre 2025.
Zimmer Biomet (NYSE:ZBH), ein globaler Marktführer im Bereich Medizintechnik, hat seine Quartalsdividende für Q3 2025 bekanntgegeben. Der Verwaltungsrat des Unternehmens genehmigte eine Bardividende in Höhe von 0,24 USD je Aktie. Die Dividende wird am oder um den 31. Oktober 2025 an die zum Geschäftsschluss am 30. September 2025 eingetragenen Aktionäre ausgezahlt.
- Consistent dividend payment demonstrates financial stability
- Maintains quarterly cash return to shareholders
- None.
AboutÌýZimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.Ìý
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit or follow on LinkedIn at or X / Twitter at .
Media | Investors | |
Kristen Cardillo | David DeMartino | |
925-786-4913 | 646-531-6115 | |
°¾±°ù²õ³Ù±ð²ÔÌý¹ó²¹±ô±ô´Ç²Ô | Ìý Zach WeinerÌý | |
781-779-5561 | 908-591-6955 | |
View original content to download multimedia:
SOURCE Zimmer Biomet Holdings, Inc.